PhoenixBio Co., Ltd. (TYO:6190)
497.00
+3.00 (0.61%)
Feb 17, 2026, 10:53 AM JST
PhoenixBio Employees
PhoenixBio had 69 employees as of March 31, 2025. The number of employees decreased by 1 or -1.43% compared to the previous year.
Employees
69
Change (1Y)
-1
Growth (1Y)
-1.43%
Revenue / Employee
23.16M JPY
Profits / Employee
-2.97M JPY
Market Cap
2.01B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 69 | -1 | -1.43% |
| Mar 31, 2024 | 70 | 5 | 7.69% |
| Mar 31, 2023 | 65 | -1 | -1.52% |
| Mar 31, 2022 | 66 | -3 | -4.35% |
| Mar 31, 2021 | 69 | -2 | -2.82% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Transgenic Group | 241 |
| Kohjin Bio | 167 |
| Soiken Holdings | 81 |
| Carna Biosciences | 63 |
| Ribomic | 25 |
| Noile-Immune Biotech | 25 |
| D. Western Therapeutics Institute | 21 |
| TMS Co., Ltd. | 18 |